Jim Cramer Weighs In Ahead Of Apple, Amazon, Eli Lilly Earnings: 'We Have To Run Such A Ridiculous Gauntlet Next Week'
Related Articles
-
Why Eli Lilly's earnings are no sure thing for traders despite obesity drug momentum
The Food and Drug Administration said supplies of Zepbound and Mounjaro are expected to be limited through the second quarter, for all but one dosage.
-
Cramer's week ahead: Fed meeting and earnings from Apple, Amazon, Eli Lilly
CNBC's Jim Cramer on Friday walked investors through next week on Wall Street.
-
Jim Cramer Sees Nvidia As Going 'From Star Of The Show To Being The Goat Of The Game'
CNBC's Jim Cramer, on Monday, highlighted the positive performance of the stock market but cautioned that the upcoming Big Tech earnings could determine the market's future. read more